Strategic Advocates’s ACM Research ACMR Stock Holding History

Strategic Advocates’s Portfolio ACMR Stock Details ACMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35	Closed	-$1.41K	–	272
2025 Q4	$1.41K	Hold	35	–	–	﹤0.01%	504
2025 Q3	$1.37K	Buy	+35	New	+$1.04K	﹤0.01%	488
2024 Q1	–	Sell	-10,938	Closed	-$214K	–	127
2023 Q4	$214K	Buy	+10,938	New	+$191K	0.09%	137

Other funds holding ACMR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return

PCP

Polunin Capital Partners London, United Kingdom $407M AUM 55.12% 1-Year Est. Return

Strategic Advocates's ACMR Position: Q1 2026 in Review

Strategic Advocates sold out of ACM Research (ACMR) in Q1 2026, closing a stake of 35 shares — an estimated $1.41K sold.

Strategic Advocates first reported a position in ACMR in Q4 2023 and held it in 3 quarters. The position peaked at $214K in Q4 2023. 300 funds tracked by Wall St. Rank hold ACMR as of Q1 2026.

Strategic Advocates reported no remaining ACM Research position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 35 ACM Research shares in Q1 2026, an estimated $1.41K.
Strategic Advocates first reported a position in ACM Research in Q4 2023 and held it in 3 quarters.
Strategic Advocates's ACM Research position peaked at $214K in Q4 2023.
300 funds tracked by Wall St. Rank held ACM Research as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.